In future work, co-administering Rosuvastatin and the TLR4/NF-κB axis agonist into the sepsis mice will be performed to identify the protection mechanism of Rosuvastatin against sepsis involving the TLR4/NF-κB axis. The gene discussed is TLR4; the disease is Sepsis.